Tralokinumab
leo pharma
['tralok', 'atopic dermatitis ', 'derm', 'tralokinumab', 'adbry', 'leo pharma']
leo pharma presents new adbrytm (tralokinumab-ldrm) safety data in moderate-to-severe atopic dermatitis at 31st eadv congress 
Breaking news from Business Wire